Specific egg yolk immunoglobulin as a promising non-antibiotic biotherapeutic product against Acinetobacter baumannii pneumonia infection
Abstract Acinetobacter baumannii is a serious health threat with a high mortality rate. We have already reported prophylactic effects of IgYs raised against OmpA and Omp34 as well as against inactivated whole-cell (IWC) of A. baumannii in a murine pneumonia model. However, the infection was exacerba...
Saved in:
Main Authors: | Abolfazl Jahangiri, Parviz Owlia, Iraj Rasooli, Jafar Salimian, Ehsan Derakhshanifar, Zahra Aghajani, Sajad Abdollahi, Saeed Khalili, Daryush Talei, Elham Darzi Eslam |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/003868d4bba647bc94e9931e3ffa91af |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potentials and limitations of microorganisms as renal failure biotherapeutics
by: Poonam Jain, et al.
Published: (2009) -
Sensitive assay design for detection of anti-drug antibodies to biotherapeutics that lack an immunoglobulin Fc domain
by: Derrick Johnson, et al.
Published: (2021) -
Gut microbiota: next frontier in understanding human health and development of biotherapeutics
by: Prakash S, et al.
Published: (2011) -
A structure-based engineering approach to abrogate pre-existing antibody binding to biotherapeutics.
by: Joanne Lin, et al.
Published: (2021) -
The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant
by: Delphine L. Lauté-Caly, et al.
Published: (2019)